Eisai: Application Submitted for Additional Indication of Anti Cancer Agent Lenvima in Combination With Keytruda as a Treatment for Advanced Renal Cell Carcinoma in Japan
- Written by ACN Newswire - Press Releases
Read more //?#
.
Time to punch above our weight and stop shadowboxing on AI
Australia prides itself on being an innovation economy. We celebrate startups, talk about productivity, and lean into our reputation for punching ...
Colter Bay Capital Launches as Australia’s Newest Institutional Private Credit Fund
Led by seasoned capital markets veteran Mark Wang, the fund is purpose-built to serve Australia’s most productive yet chronically underserved busi...
Global Thryv voices bring a sharper lens to International Women’s Day
Thryv® (NASDAQ: THRY), ANZ’s leading AI-enabled small business marketing software platform provider, marks International Women’s Day (IWD) with a bu...
AI curiosity fuels new wave of employee-led innovation in Australia
Leaders across Australia are asking themselves how they can ensure their employees get the most out of AI. We recently conducted research to help an...
Is your search bar your competitor’s best salesperson?
A few weeks ago, I was watching the Super Bowl. Traditionally, those halftime ad spots are reserved for the world’s biggest, most established bran...
AIIMS Group and AdVisible merge
Two of Australia’s most established independent agencies unite, creating marketing powerhouse backed by three decades of combined experience ...